Article
AML genomics for the clinician.
Seminars in hematology - 1 Oct 2014
Graubert Timothy, Stone Richard
Abstract excerpt
Acute myeloid leukemia (AML) is a heterogeneous disease, characterized by frequent resistance to available chemotherapeutic agents. The basic therapy for patients with AML has changed little over the past 30 years. Improvements in outcome in recent decades in younger adult cohorts have generally been ascribed to better supportive care (ie, transfusion and antimicrobial therapy); older adults with AML continue to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
